{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:46:24Z","timestamp":1782308784771,"version":"3.54.5"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s13346-025-01916-7","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T18:36:29Z","timestamp":1752604589000},"page":"2158-2178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways"],"prefix":"10.1007","volume":"16","author":[{"given":"Sabrina","family":"Banella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eride","family":"Quarta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Brandolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Grumiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Sambri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Trevisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggero","family":"Bettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Buttini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Sonvico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgeta","family":"Caraua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9033-2305","authenticated-orcid":false,"given":"Gaia","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"issue":"5","key":"1916_CR1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","volume":"39","author":"HK Siddiqi","year":"2020","unstructured":"Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020;39(5):405\u20137. https:\/\/doi.org\/10.1016\/j.healun.2020.03.012.","journal-title":"J Heart Lung Transplant"},{"key":"1916_CR2","doi-asserted-by":"publisher","unstructured":"Gaziano L, Giambartolomei C, Pereira AC, Gaulton A, Posner DC, Swanson SA, Ho YL, Iyengar SK, Kosik NM, Vujkovic M, Gagnon DR, Bento AP, Barrio-Hernandez I, R\u00f6nnblom L, Hagberg N, Lundtoft C, Langenberg C, Pietzner M, Valentine D, Gustincich S, Tartaglia GG, Allara E, Surendran P, Burgess S, Zhao JH, Peters JE, Prins BP, Angelantonio ED, Devineni P, Shi Y, Lynch KE, DuVall SL, Garcon H, Thomann LO, Zhou JJ, Gorman BR, Huffman JE, O'Donnell CJ, Tsao PS, Beckham JC, Pyarajan S, Muralidhar S, Huang GD, Ramoni R, Beltrao P, Danesh J, Hung AM, Chang KM, Sun YV, Joseph J, Leach AR, Edwards TL, Cho K, Gaziano JM, Butterworth AS, Casas JP, VA Million Veteran Program COVID-19 Science Initiative. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19. Nat Med. 2021;27(4):668\u2013676. https:\/\/doi.org\/10.1038\/s41591-021-01310-z","DOI":"10.1038\/s41591-021-01310-z"},{"key":"1916_CR3","doi-asserted-by":"publisher","first-page":"107930","DOI":"10.1016\/j.pharmthera.2021.107930","volume":"228","author":"YL Ng","year":"2021","unstructured":"Ng YL, Salim CK, Chu JJH. Drug repurposing for COVID-19: approaches, challenges and promising candidates. Pharmacol Ther. 2021;228:107930. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107930.","journal-title":"Pharmacol Ther"},{"issue":"10","key":"1916_CR4","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.cmi.2023.06.023","volume":"29","author":"N Weis","year":"2023","unstructured":"Weis N, Bollerup S, Sund JD, Glamann JB, Vinten C, Jensen LR, Sejling C, Kledal TN, Rosenkilde MM. Amantadine for COVID-19 treatment (ACT) study: a randomized, double-blinded, placebo-controlled clinical trial. Clin Microbiol Infect. 2023;29(10):1313\u20139. https:\/\/doi.org\/10.1016\/j.cmi.2023.06.023.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"1916_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-074373","volume":"14","author":"HA Cheema","year":"2024","unstructured":"Cheema HA, Jafar U, Shahid A, Masood W, Usman M, Hermis AH, Naseem MA, Sahra S, Sah R, Lee KY. Colchicine for the treatment of patients with COVID-19: an updated systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2024;14(4): e074373. https:\/\/doi.org\/10.1136\/bmjopen-2023-074373.","journal-title":"BMJ Open"},{"key":"1916_CR6","unstructured":"WHO COVID-19 Solidarity Therapeutics Trial. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/global-research-on-novel-coronavirus-2019-ncov\/solidarity-clinical-trial-for-covid-19-treatments, 2021. Accessed 11 March 2025."},{"key":"1916_CR7","unstructured":"Recovery trial. https:\/\/www.recoverytrial.net\/, 2023. Accessed 11 March 2025."},{"issue":"1","key":"1916_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40121-023-00900-3","volume":"13","author":"PO Godwin","year":"2024","unstructured":"Godwin PO, Polsonetti B, Caron MF, Oppelt TF. Remdesivir for the treatment of COVID-19: a narrative review. Infect Dis Ther. 2024;13(1):1\u201319. https:\/\/doi.org\/10.1007\/s40121-023-00900-3.","journal-title":"Infect Dis Ther"},{"key":"1916_CR9","unstructured":"European Centre for Disease Prevention and Control (ECDC). Antiviral treatment of influenza. https:\/\/www.ecdc.europa.eu\/en\/seasonal-influenza\/prevention-and-control\/antivirals, 2023. Accessed 11 March 2025."},{"key":"1916_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121704","volume":"619","author":"HC Seow","year":"2022","unstructured":"Seow HC, Liao Q, Lau ATY, Leung SWS, Yuan S, Lam JKW. Dual targeting powder formulation of antiviral agent for customizable nasal and lung deposition profile through single intranasal administration. Int J Pharm. 2022;619: 121704. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121704.","journal-title":"Int J Pharm"},{"issue":"8","key":"1916_CR11","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1080\/17425247.2023.2263363","volume":"20","author":"F Sonvico","year":"2023","unstructured":"Sonvico F, Colombo G, Quarta E, Guareschi F, Banella S, Buttini F, Scherlie\u00df R. Nasal delivery as a strategy for the prevention and treatment of COVID-19. Expert Opin Drug Deliv. 2023;20(8):1115\u201330. https:\/\/doi.org\/10.1080\/17425247.2023.2263363.","journal-title":"Expert Opin Drug Deliv"},{"issue":"9","key":"1916_CR12","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3390\/ani12091169","volume":"12","author":"A Mu\u00f1oz-Prieto","year":"2022","unstructured":"Mu\u00f1oz-Prieto A, Contreras-Aguilar MD, Cer\u00f3n JJ, Ayala I, Martin-Cuervo M, Gonzalez-Sanchez JC, Jacobsen S, Kule\u0161 J, Beleti\u0107 A, Rubi\u0107 I, Mrljak V, Tecles F, Hansen S. Changes in proteins in saliva and serum in Equine gastric ulcer syndrome using a proteomic approach. Animals. 2022;12(9):1169. https:\/\/doi.org\/10.3390\/ani12091169.","journal-title":"Animals"},{"key":"1916_CR13","doi-asserted-by":"publisher","first-page":"781968","DOI":"10.3389\/fcimb.2021.781968","volume":"11","author":"MH Shilts","year":"2022","unstructured":"Shilts MH, Rosas-Salazar C, Strickland BA, Kimura KS, Asad M, Sehanobish E, Freeman MH, Wessinger BC, Gupta V, Brown HM, Boone HH, Patel V, Barbi M, Bottalico D, O\u2019Neill M, Akbar N, Rajagopala SV, Mallal S, Phillips E, Turner JH, Jerschow E, Das SR. Severe COVID-19 Is Associated With an Altered Upper Respiratory Tract Microbiome. Front Cell Infect Microbiol. 2022;11:781968. https:\/\/doi.org\/10.3389\/fcimb.2021.781968.","journal-title":"Front Cell Infect Microbiol"},{"key":"1916_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12890-023-02348-0","volume":"23","author":"RJ Wilding","year":"2023","unstructured":"Wilding RJ, Thynne M, Subhan MMF. Optimization of sniff nasal inspiratory pressure (SNIP) measurement methodology in healthy subjects. BMC Pulm Med. 2023;23:66. https:\/\/doi.org\/10.1186\/s12890-023-02348-0.","journal-title":"BMC Pulm Med"},{"issue":"11","key":"1916_CR15","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/s1473-3099(03)00806-5","volume":"3","author":"A Savarino","year":"2003","unstructured":"Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today\u2019s diseases? Lancet Infect Dis. 2003;3(11):722\u20137. https:\/\/doi.org\/10.1016\/s1473-3099(03)00806-5.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"1916_CR16","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.26355\/eurrev_202004_21038","volume":"24","author":"SA Meo","year":"2020","unstructured":"Meo SA, Klonoff DC, Akram J. Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19. Eur Rev Med Pharmacol Sci. 2020;24(8):4539\u201347. https:\/\/doi.org\/10.26355\/eurrev_202004_21038.","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"1916_CR17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.bbrc.2020.09.128","volume":"538","author":"E Carafoli","year":"2021","unstructured":"Carafoli E. Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection. Biochem Biophys Res Commun. 2021;538:156\u201362. https:\/\/doi.org\/10.1016\/j.bbrc.2020.09.128.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"1916_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ijpharm.2015.04.003","volume":"487","author":"F Martinelli","year":"2015","unstructured":"Martinelli F, Balducci AG, Rossi A, Sonvico F, Colombo P, Buttini F. Pierce and inhale\" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs. Int J Pharm. 2015;487(1\u20132):197\u2013204. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.04.003.","journal-title":"Int J Pharm"},{"issue":"7","key":"1916_CR19","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.apsb.2020.04.007","volume":"10","author":"C Cui","year":"2020","unstructured":"Cui C, Zhang M, Yao X, Tu S, Hou Z, Jie En VS, Xiang X, Lin J, Cai T, Shen N, Song C, Qiao J, Zhang S, Li H, Liu D. Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model. Acta Pharm Sin B. 2020;10(7):1216\u201327. https:\/\/doi.org\/10.1016\/j.apsb.2020.04.007.","journal-title":"Acta Pharm Sin B"},{"key":"1916_CR20","first-page":"835","volume":"3","author":"F Buttini","year":"2012","unstructured":"Buttini F, Cuoghi E, Miozzi M, Rossi A, Sonvico F, Colombo P. Insulin spray-dried powder and smoothed lactose: a new formulation strategy for nasal and pulmonary delivery. Respir Drug Deliv. 2012;3:835\u201340.","journal-title":"Respir Drug Deliv"},{"key":"1916_CR21","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.powtec.2021.01.010","volume":"383","author":"D M\u00fcller","year":"2021","unstructured":"M\u00fcller D, Fimbinger E, Brand C. Algorithm for the determination of the angle of repose in bulk material analysis. Powder Technol. 2021;383:598\u2013605. https:\/\/doi.org\/10.1016\/j.powtec.2021.01.010.","journal-title":"Powder Technol"},{"key":"1916_CR22","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jconrel.2020.04.015","volume":"323","author":"E Quarta","year":"2020","unstructured":"Quarta E, Chierici V, Flammini L, Tognolini M, Barocelli E, Cantoni AM, Dujovny G, Ecenarro Probst S, Sonvico F, Colombo G, Rossi A, Bettini R, Colombo P, Buttini F. Excipient-free pulmonary insulin dry powder: pharmacokinetic and pharmacodynamics profiles in rats. J Control Release. 2020;323:412\u201320. https:\/\/doi.org\/10.1016\/j.jconrel.2020.04.015.","journal-title":"J Control Release"},{"issue":"1","key":"1916_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ijpharm.2018.06.006","volume":"548","author":"F Buttini","year":"2018","unstructured":"Buttini F, Balducci AG, Colombo G, Sonvico F, Montanari S, Pisi G, Rossi A, Colombo P, Bettini R. Dose administration maneuvers and patient care in tobramycin dry powder inhalation therapy. Int J Pharm. 2018;548(1):182\u201391. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.06.006.","journal-title":"Int J Pharm"},{"issue":"2","key":"1916_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ijpharm.2012.09.049","volume":"440","author":"AG Balducci","year":"2013","unstructured":"Balducci AG, Ferraro L, Bortolotti F, Nastruzzi C, Colombo P, Sonvico F, Russo P, Colombo G. Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats. Int J Pharm. 2013;440(2):154\u201360. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.09.049.","journal-title":"Int J Pharm"},{"issue":"9","key":"1916_CR25","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1080\/1061186X.2019.1574300","volume":"27","author":"L Tiozzo Fasiolo","year":"2019","unstructured":"Tiozzo Fasiolo L, Manniello MD, Bortolotti F, Buttini F, Rossi A, Sonvico F, Colombo P, Valsami G, Colombo G, Russo P. Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer\u2019s disease. J Drug Target. 2019;27(9):984\u201394. https:\/\/doi.org\/10.1080\/1061186X.2019.1574300.","journal-title":"J Drug Target"},{"issue":"1","key":"1916_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.wjorl.2017.02.004","volume":"3","author":"KY Choi","year":"2017","unstructured":"Choi KY, Cho SW, Choi JJ, Zhang YL, Kim DW, Han DH, Kim HJ, Kim DY, Rhee CS, Won TB. Healing of the nasal septal mucosa in an experimental rabbit model of mucosal injury. World Journal of Otorhinolaryngology. 2017;3(1):17\u201323. https:\/\/doi.org\/10.1016\/j.wjorl.2017.02.004.","journal-title":"World Journal of Otorhinolaryngology"},{"issue":"1","key":"1916_CR27","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1038\/s41598-022-07301-5","volume":"12","author":"TJ Johnson","year":"2022","unstructured":"Johnson TJ, Nishida RT, Sonpar AP, Lin YJ, Watson KA, Smith SW, Conly JM, Evans DH, Olfert JS. Viral load of SARS-CoV-2 in droplets and bioaerosols directly captured during breathing, speaking and coughing. Sci Rep. 2022;12(1):3484. https:\/\/doi.org\/10.1038\/s41598-022-07301-5.","journal-title":"Sci Rep"},{"issue":"9","key":"1916_CR28","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/S2213-2600(20)30354-4","volume":"8","author":"E Pujadas","year":"2020","unstructured":"Pujadas E, Chaudhry F, McBride R, Richter F, Zhao S, Wajnberg A, Nadkarni G, Glicksberg BS, Houldsworth J, Cordon-Cardo C. SARS-CoV-2 viral load predicts COVID-19 mortality. Lancet Respir Med. 2020;8(9):e70. https:\/\/doi.org\/10.1016\/S2213-2600(20)30354-4.","journal-title":"Lancet Respir Med"},{"key":"1916_CR29","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.69302","volume":"10","author":"A Marc","year":"2021","unstructured":"Marc A, Kerioui M, Blanquart F, Bertrand J, Mitj\u00e0 O, Corbacho-Monn\u00e9 M, Marks M, Guedj J. Quantifying the relationship between SARS-CoV-2 viral load and infectiousness. Elife. 2021;10: e69302. https:\/\/doi.org\/10.7554\/eLife.69302.","journal-title":"Elife"},{"issue":"1","key":"1916_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/diagnostics12010147","volume":"12","author":"SA Kiryanov","year":"2022","unstructured":"Kiryanov SA, Levina TA, Konopleva MV, Suslov AP. Identification of hotspot mutations in the N gene of SARS-CoV-2 in Russian clinical samples that may affect the detection by reverse transcription-PCR. Diagnostics. 2022;12(1):147. https:\/\/doi.org\/10.3390\/diagnostics12010147.","journal-title":"Diagnostics"},{"issue":"6","key":"1916_CR31","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/v13061022","volume":"13","author":"M Brandolini","year":"2021","unstructured":"Brandolini M, Taddei F, Marino MM, Grumiro L, Scalcione A, Turba ME, Gentilini F, Fantini M, Zannoli S, Dirani G, Sambri V. Correlating qRT-PCR, dPCR and viral titration for the identification and quantification of SARS-CoV-2: a new approach for infection management. Viruses. 2021;13(6):1022. https:\/\/doi.org\/10.3390\/v13061022.","journal-title":"Viruses"},{"issue":"21","key":"1916_CR32","doi-asserted-by":"publisher","first-page":"15725","DOI":"10.3390\/ijms242115725","volume":"24","author":"S Banella","year":"2023","unstructured":"Banella S, Saraswat A, Patel A, Serajuddin ATM, Colombo P, Patel K, Colombo G. In vitro assessment of Cisplatin\/Hyaluronan complex for loco-regional chemotherapy. Int J Mol Sci. 2023;24(21):15725. https:\/\/doi.org\/10.3390\/ijms242115725.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1916_CR33","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.3390\/cancers15082244","volume":"15","author":"E Claes","year":"2023","unstructured":"Claes E, Wener R, Neyrinck AP, Coppens A, Van Schil PE, Janssens A, Lapperre TS, Snoeckx A, Wen W, Voet H, Verleden SE, Hendriks JMH. Innovative invasive loco-regional techniques for the treatment of lung cancer. Cancers (Basel). 2023;15(8):2244. https:\/\/doi.org\/10.3390\/cancers15082244.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1916_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105923","volume":"55","author":"P Colson","year":"2020","unstructured":"Colson P, Rolain JM, Raoult D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents. 2020;55(3): 105923. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105923.","journal-title":"Int J Antimicrob Agents"},{"key":"1916_CR35","doi-asserted-by":"publisher","unstructured":"Browning DJ. Pharmacology of Chloroquine and Hydroxychloroquine. In: D.J. Browning DJ, editor. Hydroxychloroquine and Chloroquine Retinopathy. New York: Springer; 2014. pp. 35\u201363. https:\/\/doi.org\/10.1007\/978-1-4939-0597-3_2","DOI":"10.1007\/978-1-4939-0597-3_2"},{"key":"1916_CR36","doi-asserted-by":"publisher","unstructured":"Sheahan TP, Sims AC, Zhou S, Graham RL, Pruijssers AJ, Agostini ML, Leist SR, Sch\u00e4fer A, Dinnon 3rd KH, Stevens LJ, Chappell JD, Lu X, Hughes TM, George AS, Hill CS, Montgomery SA, Brown AJ, Bluemling GR, Natchus MG, Saindane M, Kolykhalov AA, Painter G, Harcourt J, Tamin A, Thornburg NJ, Swanstrom R, Denison MR, Baric RS. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci. Transl. Med. 2020;12:eabb5883. https:\/\/doi.org\/10.1126\/scitranslmed.abb5883","DOI":"10.1126\/scitranslmed.abb5883"},{"issue":"1","key":"1916_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/cid\/ciac180","volume":"76","author":"LD Saravolatz","year":"2023","unstructured":"Saravolatz LD, Depcinski S, Sharma M. Molnupiravir and Nirmatrelvir-Ritonavir: Oral Coronavirus Disease 2019. Antiviral Drugs, Clin Infect Dis. 2023;76(1):165\u201371. https:\/\/doi.org\/10.1093\/cid\/ciac180.","journal-title":"Antiviral Drugs, Clin Infect Dis"},{"issue":"10","key":"1916_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109180","volume":"9","author":"J Xue","year":"2014","unstructured":"Xue J, Moyer A, Peng B, Wu J, Hannafon BN, Ding WQ. Chloroquine is a zinc ionophore. PLoS ONE. 2014;9(10): e109180. https:\/\/doi.org\/10.1371\/journal.pone.0109180.","journal-title":"PLoS ONE"},{"key":"1916_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cherd.2016.03.007","volume":"110","author":"A Porowska","year":"2016","unstructured":"Porowska A, Dosta M, Fries L, Gianfrancesco A, Heinrich S, Palzer S. Predicting the surface composition of a spray-dried particle by modelling component reorganization in a drying droplet. Chem Eng Res Des. 2016;110:131\u201340. https:\/\/doi.org\/10.1016\/j.cherd.2016.03.007.","journal-title":"Chem Eng Res Des"},{"issue":"1","key":"1916_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1046\/j.1365-2273.1999.00223.x","volume":"24","author":"RJ England","year":"1999","unstructured":"England RJ, Homer JJ, Knight LC, Ell SR. Nasal pH measurement: a reliable and repeatable parameter. Clin Otolaryngol Allied Sci. 1999;24(1):67\u20138. https:\/\/doi.org\/10.1046\/j.1365-2273.1999.00223.x.","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"2","key":"1916_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s0378-5173(99)00442-1","volume":"198","author":"N Washington","year":"2000","unstructured":"Washington N, Steele RJ, Jackson SJ, Bush D, Mason J, Gill DA, Pitt K, Rawlins DA. Determination of baseline human nasal pH and the effect of intranasally administered buffers. Int J Pharm. 2000;198(2):139\u201346. https:\/\/doi.org\/10.1016\/s0378-5173(99)00442-1.","journal-title":"Int J Pharm"},{"issue":"1","key":"1916_CR42","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ijpharm.2017.09.018","volume":"532","author":"J Leal","year":"2017","unstructured":"Leal J, Smyth HDC, Ghosh D. Physicochemical properties of mucus and their impact on transmucosal drug delivery. Int J Pharm. 2017;532(1):555\u201372. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.09.018.","journal-title":"Int J Pharm"},{"key":"1916_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2020.111219","volume":"194","author":"B\u00c1 Szil\u00e1gyi","year":"2020","unstructured":"Szil\u00e1gyi B\u00c1, Mammadova A, Gyarmati B, Szil\u00e1gyi A. Mucoadhesive interactions between synthetic polyaspartamides and porcine gastric mucin on the colloid size scale. Colloids Surf B Biointerfaces. 2020;194: 111219. https:\/\/doi.org\/10.1016\/j.colsurfb.2020.111219.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"1916_CR44","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/s0166-3542(01)00195-4","volume":"52","author":"BW van der Strate","year":"2001","unstructured":"van der Strate BW, Beljaars L, Molema G, Harmsen MC, Meijer DK. Antiviral activities of lactoferrin. Antivir Res. 2001;52(3):225\u201339. https:\/\/doi.org\/10.1016\/s0166-3542(01)00195-4.","journal-title":"Antivir Res"},{"key":"1916_CR45","doi-asserted-by":"publisher","first-page":"666600","DOI":"10.3389\/fphar.2021.666600","volume":"12","author":"E Campione","year":"2021","unstructured":"Campione E, Lanna C, Cosio T, Rosa L, Conte MP, Iacovelli F, Romeo A, Falconi M, Del Vecchio C, Franchin E, Lia MS, Minieri M, Chiaramonte C, Ciotti M, Nuccetelli M, Terrinoni A, Iannuzzi I, Coppeda L, Magrini A, Bernardini S, Sabatini S, Rosapepe F, Bartoletti PL, Moricca N, Di Lorenzo A, Andreoni M, Sarmati L, Miani A, Piscitelli P, Valenti P, Bianchi L. Lactoferrin against SARS-CoV-2. In vitro and in silico evidences. Front Pharmacol. 2021;12:666600. https:\/\/doi.org\/10.3389\/fphar.2021.666600.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1916_CR46","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10534-022-00455-9","volume":"36","author":"R Ong","year":"2023","unstructured":"Ong R, Cornish J, Wen J. Nanoparticular and other carriers to deliver lactoferrin for antimicrobial, antibiofilm and bone-regenerating effects: a review. Biometals. 2023;36(3):709\u201327. https:\/\/doi.org\/10.1007\/s10534-022-00455-9.","journal-title":"Biometals"},{"key":"1916_CR47","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.addr.2020.09.002","volume":"170","author":"S Le Guellec","year":"2021","unstructured":"Le Guellec S, Ehrmann S, Vecellio L. In vitro - in vivo correlation of intranasal drug deposition. Adv Drug Deliv Rev. 2021;170:340\u201352. https:\/\/doi.org\/10.1016\/j.addr.2020.09.002.","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"1916_CR48","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3109\/03639045.2016.1160110","volume":"42","author":"M Pozzoli","year":"2016","unstructured":"Pozzoli M, Rogueda P, Zhu B, Smith T, Young PM, Traini D, Sonvico F. Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation. Drug Dev Ind Pharm. 2016;42(10):1660\u20138. https:\/\/doi.org\/10.3109\/03639045.2016.1160110.","journal-title":"Drug Dev Ind Pharm"},{"issue":"16","key":"1916_CR49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2119680119","volume":"119","author":"CB Morrison","year":"2022","unstructured":"Morrison CB, Edwards CE, Shaffer KM, Araba KC, Wykoff JA, Williams DR, Asakura T, Dang H, Morton LC, Gilmore RC, O\u2019Neal WK, Boucher RC, Baric RS, Ehre C. SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13. Proc Natl Acad Sci U S A. 2022;119(16): e2119680119. https:\/\/doi.org\/10.1073\/pnas.2119680119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1916_CR50","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1136\/thoraxjnl-2021-217561","volume":"77","author":"JP Bridges","year":"2022","unstructured":"Bridges JP, Vladar EK, Huang H, Mason RJ. Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19. Thorax. 2022;77(2):203\u20139. https:\/\/doi.org\/10.1136\/thoraxjnl-2021-217561.","journal-title":"Thorax"},{"key":"1916_CR51","unstructured":"European Pharmacopoeia 11th ed., 2.9.36. Powder Flow (07\/2024), Suppl. 11.5: 5834\u20135836."},{"key":"1916_CR52","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.powtec.2018.02.003","volume":"330","author":"HM Beakawi Al-Hashemi","year":"2018","unstructured":"Beakawi Al-Hashemi HM, Baghabra Al-Amoudi OS. A review on the angle of repose of granular materials. Powder Technol. 2018;330:397\u2013417. https:\/\/doi.org\/10.1016\/j.powtec.2018.02.003.","journal-title":"Powder Technol"},{"key":"1916_CR53","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jaerosci.2007.04.005","volume":"38","author":"R Vehring","year":"2007","unstructured":"Vehring R, Foss WR, Lechuga-Ballesteros D. Particle formation in spray drying. J Aerosol Sci. 2007;38:728\u201346. https:\/\/doi.org\/10.1016\/j.jaerosci.2007.04.005.","journal-title":"J Aerosol Sci"},{"issue":"2","key":"1916_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40261-023-01330-2","volume":"44","author":"TGD Capstick","year":"2024","unstructured":"Capstick TGD, Gudimetla S, Harris DS, Malone R, Usmani OS. Demystifying dry powder inhaler resistance with relevance to optimal patient care. Clin Drug Investig. 2024;44(2):109\u201314. https:\/\/doi.org\/10.1007\/s40261-023-01330-2.","journal-title":"Clin Drug Investig"},{"issue":"84","key":"1916_CR55","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejps.2016.01.005","volume":"10","author":"KT Ung","year":"2016","unstructured":"Ung KT, Chan HK. Effects of ramp-up of inspired airflow on in vitro aerosol dose delivery performance for certain dry powder inhalers. Eur J Pharm Sci. 2016;10(84):46\u201354. https:\/\/doi.org\/10.1016\/j.ejps.2016.01.005.","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"1916_CR56","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1089\/jamp.2020.29028.whf","volume":"33","author":"WH Finlay","year":"2020","unstructured":"Finlay WH, Darquenne C. Particle size distributions. J Aerosol Med Pulm Drug Deliv. 2020;33(4):178\u201380. https:\/\/doi.org\/10.1089\/jamp.2020.29028.whf.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"1916_CR57","doi-asserted-by":"publisher","first-page":"122042","DOI":"10.1016\/j.ijpharm.2022.122042","volume":"624","author":"T Saha","year":"2022","unstructured":"Saha T, Qui\u00f1ones-Mateu ME, Das SC. Inhaled therapy for COVID-19: considerations of drugs, formulations and devices. Int J Pharm. 2022;624:122042. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122042.","journal-title":"Int J Pharm"},{"key":"1916_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2021.100073","volume":"3","author":"S Sahakijpijarn","year":"2021","unstructured":"Sahakijpijarn S, Moon C, Warnken ZN, Maier EY, DeVore JE, Christensen DJ, Koleng JJ, Williams RO 3rd. In vivo pharmacokinetic study of remdesivir dry powder for inhalation in hamsters. Int J Pharm X. 2021;3: 100073. https:\/\/doi.org\/10.1016\/j.ijpx.2021.100073.","journal-title":"Int J Pharm X"},{"issue":"8","key":"1916_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272034","volume":"17","author":"YA de Reus","year":"2022","unstructured":"de Reus YA, Hagedoorn P, Sturkenboom MGG, Grasmeijer F, Bolhuis MS, Sibum I, Kerstjens HAM, Frijlink HW, Akkerman OW. Tolerability and pharmacokinetic evaluation of inhaled dry powder hydroxychloroquine in healthy volunteers. PLoS ONE. 2022;17(8): e0272034. https:\/\/doi.org\/10.1371\/journal.pone.0272034.","journal-title":"PLoS ONE"},{"issue":"8","key":"1916_CR60","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1021\/je8007099","volume":"54","author":"A Daneshfar","year":"2009","unstructured":"Daneshfar A, Vafafard S. Solubility of chloroquine diphosphate and 4,7-dichloroquinoline in water, ethanol, tetrahydrofuran, acetonitrile, and acetone from (298.2 to 333.2) K. J Chem Eng Data. 2009;54(8):2170\u20133. https:\/\/doi.org\/10.1021\/je8007099.","journal-title":"J Chem Eng Data"},{"issue":"7","key":"1916_CR61","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1021\/acs.molpharmaceut.0c00163","volume":"17","author":"G Frenning","year":"2020","unstructured":"Frenning G, van der Zwaan I, Franek F, Fransson R, Tehler U. Model for the analysis of membrane-type dissolution tests for inhaled drugs. Mol Pharm. 2020;17(7):2426\u201334. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00163.","journal-title":"Mol Pharm"},{"key":"1916_CR62","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ejps.2017.09.027","volume":"113","author":"L Tiozzo Fasiolo","year":"2018","unstructured":"Tiozzo Fasiolo L, Manniello MD, Tratta E, Buttini F, Rossi A, Sonvico F, Bortolotti F, Russo P, Colombo G. Opportunity and challenges of nasal powders: drug formulation and delivery. Eur J Pharm Sci. 2018;113:2\u201317. https:\/\/doi.org\/10.1016\/j.ejps.2017.09.027.","journal-title":"Eur J Pharm Sci"},{"issue":"15","key":"1916_CR63","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/cid\/ciaa237","volume":"71","author":"X Yao","year":"2020","unstructured":"Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, Zhan S, Lu R, Li H, Tan W, Liu D. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020;71(15):732\u20139. https:\/\/doi.org\/10.1093\/cid\/ciaa237.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1916_CR64","first-page":"94","volume":"13","author":"Y Hu","year":"2021","unstructured":"Hu Y, Li YV. The change of intracellular zinc distribution after strong acid challenge. Int J Physiol Pathophysiol Pharmacol. 2021;13(3):94\u2013101.","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"issue":"4","key":"1916_CR65","doi-asserted-by":"publisher","first-page":"301.e1","DOI":"10.1016\/j.ijantimicag.2008.07.020","volume":"33","author":"SA Gonz\u00e1lez-Ch\u00e1vez","year":"2009","unstructured":"Gonz\u00e1lez-Ch\u00e1vez SA, Ar\u00e9valo-Gallegos S, Rasc\u00f3n-Cruz Q. Lactoferrin: structure, function and applications. Int J Antimicrob Agents. 2009;33(4):301.e1-8. https:\/\/doi.org\/10.1016\/j.ijantimicag.2008.07.020.","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"1916_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00216-0","volume":"2","author":"M Essaidi-Laziosi","year":"2021","unstructured":"Essaidi-Laziosi M, Perez Rodriguez FJ, Hulo N, Jacquerioz F, Kaiser L, Eckerle I. Estimating clinical SARS-CoV-2 infectiousness in Vero E6 and primary airway epithelial cells. Lancet Microbe. 2021;2(11): e571. https:\/\/doi.org\/10.1016\/S2666-5247(21)00216-0.","journal-title":"Lancet Microbe"},{"key":"1916_CR67","doi-asserted-by":"publisher","unstructured":"Rosa RB, Dantas WM, do Nascimento JFC, da Silva MV, de Oliveira RN, Pena LJ. In Vitro and In Vivo Models for Studying SARS-CoV-2, the Etiological Agent Responsible for COVID-19 Pandemic. Viruses 2021;13(3):379. https:\/\/doi.org\/10.3390\/v13030379","DOI":"10.3390\/v13030379"},{"issue":"3","key":"1916_CR68","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269\u201371. https:\/\/doi.org\/10.1038\/s41422-020-0282-0.","journal-title":"Cell Res"},{"key":"1916_CR69","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","volume":"6","author":"J Liu","year":"2020","unstructured":"Liu J, Cao R, Xu M, Wang X, Zhang H, Hu H, Li Y, Hu Z, Zhong W, Wang M. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020;6:16. https:\/\/doi.org\/10.1038\/s41421-020-0156-0.","journal-title":"Cell Discov"},{"key":"1916_CR70","doi-asserted-by":"publisher","first-page":"101873","DOI":"10.1016\/j.tmaid.2020.101873","volume":"37","author":"M Gendrot","year":"2020","unstructured":"Gendrot M, Andreani J, Boxberger M, Jardot P, Fonta I, Le Bideau M, Duflot I, Mosnier J, Rolland C, Bogreau H, Hutter S, La Scola B, Pradines B. Antimalarial drugs inhibit the replication of SARS-CoV-2: an in vitro evaluation. Travel Med Infect Dis. 2020;37:101873. https:\/\/doi.org\/10.1016\/j.tmaid.2020.101873.","journal-title":"Travel Med Infect Dis"},{"key":"1916_CR71","unstructured":"Shittu MO, Afolami OI. Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives - A better synergy for future COVID-19 clinical trials. Le Infezioni in Medicina; 2020;28(2):192\u2013197. https:\/\/infezmed.it\/media\/journal\/Vol_28_2_2020_9.pdf Accessed 17 March 2025."},{"key":"1916_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.109815","volume":"142","author":"R Derwand","year":"2020","unstructured":"Derwand R, Scholz M. Does zinc supplementation enhance the clinical efficacy of chloroquine\/hydroxychloroquine to win today\u2019s battle against COVID-19? Med Hypotheses. 2020;142: 109815. https:\/\/doi.org\/10.1016\/j.mehy.2020.109815.","journal-title":"Med Hypotheses"},{"issue":"3","key":"1916_CR73","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/03639040903170750","volume":"36","author":"L Jiang","year":"2010","unstructured":"Jiang L, Gao L, Wang X, Tang L, Ma J. The application of mucoadhesive polymers in nasal drug delivery. Drug Dev Ind Pharm. 2010;36(3):323\u201336. https:\/\/doi.org\/10.1080\/03639040903170750.","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"1916_CR74","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/22221751","volume":"10","author":"Y Hu","year":"2021","unstructured":"Hu Y, Meng X, Zhang F, Xiang Y, Wang J. The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor. Emerg Microbes Infect. 2021;10(1):317\u201330. https:\/\/doi.org\/10.1080\/22221751.","journal-title":"Emerg Microbes Infect"},{"key":"1916_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2022.111777","volume":"231","author":"X Tao","year":"2022","unstructured":"Tao X, Zhang L, Du L, Lu K, Zhao Z, Xie Y, Li X, Huang S, Wang PH, Pan JA, Xia W, Dai J, Mao ZW. Inhibition of SARS-CoV-2 replication by zinc gluconate in combination with hinokitiol. J Inorg Biochem. 2022;231: 111777. https:\/\/doi.org\/10.1016\/j.jinorgbio.2022.111777.","journal-title":"J Inorg Biochem"},{"key":"1916_CR76","doi-asserted-by":"publisher","first-page":"104904","DOI":"10.1016\/j.phrs.2020.104904","volume":"158","author":"E Quiros Roldan","year":"2020","unstructured":"Quiros Roldan E, Biasiotto G, Magro P, Zanella I. The possible mechanisms of action of 4-aminoquinolines (chloroquine\/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): a role for iron homeostasis? Pharmacol Res. 2020;158:104904. https:\/\/doi.org\/10.1016\/j.phrs.2020.104904.","journal-title":"Pharmacol Res"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01916-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01916-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01916-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:50:41Z","timestamp":1782305441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01916-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1916"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01916-7","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"28 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Research Ethics Board of the University of Parma (June 11th, 2024, protocol number 0145714).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all healthy volunteers for being included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Emeritus Professor Paolo Colombo is the administrator of the innovative SME PlumeStars s.r.l., the Applicant of an Italian patent on \u201cNovel Antiviral Compositions and Their Use in Therapy and in the Treatment of Viral Infections\u201d (No. 102021000002003, filed on 01\/02\/2021). Paolo Colombo, Eride Quarta, Gaia Colombo and Sabrina Banella are the inventors of that patent. Ruggero Bettini and Francesca Buttini, both professors of Pharmaceutical Technology at the\u00a0Food and Drug\u00a0Department of the University of Parma, are co-founders of PlumeStars start-up. The other authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}